Cantlay Harper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK settles U.S. Zantac lawsuit, avoiding trial. Confidential settlements reinforce commitment to legal efficiency.

GSK PLC's (LSE:GSK, NYSE:GSK) latest out-of-court Zantac deal is important to the ongoing "overhang" over the investment case, Citigroup said. The US...

Citi and J.P. Morgan estimate GSK's total liability related to the lawsuits to amount to about $5 billion. The trial for the Cantlay/Harper case, which was set to begin on Nov. 13, will now be dismissed, GSK said, adding it had also settled three remaining breast cancer cases in California related to the same drug. The latest settlements in California related to cases due to go to trial in November, with a further set scheduled to begin in Delaware courts in January, GSK said.

GSK on Wednesday said it had reached a confidential settlement on a litigation in California over claims that the British drugmaker's heartburn drug Zantac caused cancer. The trial for...

Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day. The minutes are being released...